NewAmsterdam Pharma Files 8-K on Shareholder Votes & Financials
Ticker: NAMSW · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1936258
Sentiment: neutral
Topics: corporate-action, financials, filing
Related Tickers: NAMS
TL;DR
NAMS filed an 8-K on June 4th covering shareholder votes and financials.
AI Summary
NewAmsterdam Pharma Co N.V. filed an 8-K on June 6, 2025, reporting on matters submitted to a vote of security holders and financial statements as of June 4, 2025. The filing also includes information about common stock and warrants.
Why It Matters
This filing provides updates on corporate actions and financial reporting for NewAmsterdam Pharma, which is relevant for investors tracking the company's governance and financial health.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- NewAmsterdam Pharma Co N.V. (company) — Registrant
- June 4, 2025 (date) — Earliest event reported
- June 6, 2025 (date) — Date of report
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that 'Submission of Matters to a Vote of Security Holders' is an item reported, but the specific details of these matters are not provided in the excerpt.
What financial statements are included in this filing?
The filing states that 'Financial Statements and Exhibits' are included, but the specific financial statements are not detailed in the provided text.
What is the company's primary business?
NewAmsterdam Pharma Co N.V. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
When was the company incorporated or jurisdiction of origin?
The company's jurisdiction of incorporation is listed as 'The Netherlands'.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding NewAmsterdam Pharma Co N.V. (NAMSW).